NEW YORK (GenomeWeb News) – The Environmental Protection Agency is preparing to implement a strategic plan for how it will evaluate toxic chemical risks in the future that will lean heavily on genomics and molecular biology.

The unique demands of toxic analysis includes a need for increased knowledge about life-stage vulnerabilities, genetic susceptibilities, and bearing an increase in the expense of toxic testing have pushed EPA to develop "a new approach" that is based on advances in molecular biology and computational sciences, EPA said this week.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.